ETrade Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.16M Buy
5,300
+954
+22% +$202K 0.02% 326
2020
Q2
$829K Buy
4,346
+1,333
+44% +$234K 0.02% 411
2020
Q1
$467K Sell
3,013
-77
-2% -$8.96K 0.01% 486
2019
Q4
$259K Sell
3,090
-673
-18% -$51.2K 0.01% 711
2019
Q3
$255K Buy
3,763
+614
+19% +$40.4K 0.01% 717
2019
Q2
$209K Buy
+3,149
New +$184K 0.01% 762

Other funds holding TDOC

ETrade Capital Management's TDOC Position: Q3 2020 in Review

ETrade Capital Management increased its Teladoc Health (TDOC) stake by 22% in Q3 2020, buying an estimated $202K and bringing the position to 5,300 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #326.

ETrade Capital Management first reported a position in TDOC in Q2 2019 and has held it in 6 quarters since. 744 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • ETrade Capital Management held 5,300 shares of Teladoc Health worth $1.16M as of Q3 2020.
  • ETrade Capital Management bought 954 Teladoc Health shares in Q3 2020, an estimated $202K.
  • Teladoc Health made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #326 holding.
  • ETrade Capital Management first reported a position in Teladoc Health in Q2 2019 and has held it in 6 quarters since.
  • 744 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.